NDC 72603-408

NDC codes

FDA NDC Directory

Product NDC (as listed)72603-408Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72603-0408Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72603-408-01	72603040801	1 VIAL, SINGLE-USE in 1 CARTON (72603-408-01) / 20 mL in 1 VIAL, SINGLE-USEMarketed from Sep 10, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Paclitaxel protein-bound particles for injectable suspension (albumin-bound)
Generic name (nonproprietary): paclitaxel
Active ingredients: Paclitaxel — 100 mg/20mL
Dosage form: Injection, Powder, Lyophilized, For suspension
Route: Intravenous
Labeler: NorthStar Rx LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216355
Marketing start: Sep 10, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Microtubule Inhibition (Physiologic effect)
Identifiers: Product ID 72603-408_1b25114a-fb04-4ec5-a5c0-6868f36116d6SPL ID 1b25114a-fb04-4ec5-a5c0-6868f36116d6SPL set ID 1e9d5093-fbfc-470a-8520-811c46a8870cRxCUI 583214UNII P88XT4IS4DUPC 0372603408010
Pharmacologic class: Microtubule Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N472603040801 followed by a unit qualifier and the quantity

Package 72603-0408-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 17, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Paclitaxel protein-bound particles for injectable suspension (albumin-bound) is a microtubule inhibitor indicated for the treatment of: • Metastatic breast cancer, after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated. ( 1.1 ) • Locally advanced or metastatic non-small cell lung cancer (NSCLC), as first-line treatment in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy. ( 1.2 ) • Metastatic adenocarcinoma of the pancreas as first-line treatment, in combination with gemcitabine. ( 1.3 ) 1…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 216355

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216355
Product	Strength	Form · route	Labeler	Product NDC
Paclitaxel protein-bound particles for injectable suspension (albumin-bound)paclitaxel	Paclitaxel 100 mg/20mL	Injection, Powder, Lyophilized, For suspensionIntravenous	Meitheal Pharmaceuticals Inc.	71288-183
Paclitaxelpaclitaxel (aibumin-bound)	Paclitaxel 100 mg/100mg	Injection, Powder, Lyophilized, For suspensionIntravenous	Ningbo Shuangcheng Pharmaceutical Co., Ltd	75007-041
Paclitaxel protein-bound particles for injectable suspension (albumin-bound)paclitaxel	Paclitaxel 100 mg/20mL	Injection, Powder, Lyophilized, For suspensionIntravenous	BluePoint Laboratories	68001-651

Paclitaxel protein-bound particles for injectable suspension (albumin-bound) NDC 72603-408